Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer/site build has been updated from Revision v3.5.2 to v3.5.3, reflecting a website release rather than any change to the clinical trial information.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2. This appears to be a metadata update rather than a substantive change to the study content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedSite revision updated to Revision: v3.4.2, replacing the previous Revision: v3.4.1 banner. The funding-status notice about government funding delays was removed, with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedA government funding lapse notice was added at the top of the page informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. Updated site revision to v3.4.1 and removed v3.4.0 reference.SummaryDifference0.3%

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.